Regulation & law · 01/07/2013Updated: 10/17/2026 · 1 min read
Patheon Pharmaceuticals, Inc. Files Notice of Registration with the U.S. Drug Enforcement Administration for Controlled Substances
Summary
Patheon Pharmaceuticals, Inc. has submitted a notice of registration to the U.S. Drug Enforcement Administration for the manufacture of controlled substances, as required by law.
Original source language: Federal Register — Justice DepartmentOpen original release →